diabetes drugs

Health figures show steep rise in use of diabetes drugs in UK

by Barbara Hewitt on August 3, 2017

It is well known that the number of people with diabetes is growing around the world but new figures from the UK reveal just how many more are now taking medication to control the condition.

Prescriptions for diabetes drugs from the National Health Serviced have doubled to over 50 million in the last 10 years and family doctors are now spending a tenth of their medicines budget on diabetes.

(HD_Premium_shots/Bigstock.com)

Simon O’Neill, director of health intelligence for charity Diabetes UK, said the rise is not a surprise as the number of people diagnosed with diabetes has risen by 54% over the same period, but the figures show how much the cost is in terms of drugs.

‘Diabetes is one of our biggest health crises, and with 12 million people at risk of developing type 2 diabetes, it’s clear that focusing on prevention is vital to prevent costs rising even higher,’ he said.

But he also paid tribute to the doctors who are helping to make sure people with diabetes get the right medication and help them to keep their blood glucose at safe levels, thus preventing devastating, and costly, complications such as cardiovascular and kidney disease further down the line.

The figures show that prescribing for diabetes in primary care has grown nearly twice as quickly as the rise in diabetes prevalence across the population at 40% compared to 22.6%. Prescriptions for the most commonly prescribed diabetes drug, metformin, rose by 51.5%.

Looking across the whole of the last decade, prescribing of metformin for diabetes has more than doubled, from 9.4 million items in 2006/2007 to 20.8 million items in 2016/2017.

In 2016/2017 prescription items for diabetes accounted for around £1 in every £9 of the cost of prescription items across primary care. In 2006/2007 it was less than £1 in every £14.

It also shows that the cost of diabetes drugs has increased over the last year, compared to the cost of prescriptions across primary care falling overall and has been the case since 2007/2008.

Between 2015/2016 and 2016/2017, there was a marginal reduction in the overall cost of prescription items across primary care, with the figure falling below £9 billion. But, over this period, there was a £27 million increase for diabetes which totalled £983.7 million in 2016/2017.

The Prescribing for Diabetes report also shows that drugs classified as other antidiabetic drugs, often new products to the market, are the most expensive category of drugs used in diabetes, for the first time overtaking the cost of human analogue insulin.

They account for a low proportion of all items prescribed for diabetes, but that figure is rising. In 2016/2017 they cost £322.5 million, compared with £103.0 million in 2006/2007.

{ 0 comments }

Thumbnail image for Scientists working on developing type 2 diabetes drugs with fewer side effects

Scientists working on developing type 2 diabetes drugs with fewer side effects

June 20, 2016 News

Designing more effective medicines to treat type 2 diabetes with fewer side effects is a step closer thanks to an international research project. The study gives a greater understanding about how some diabetic drugs work at a molecular level and, more importantly, identifying how they can give mixed or biased messages and scientists say that […]

Read the full article →
Thumbnail image for Study confirms increased risk of bladder cancer with diabetes drug

Study confirms increased risk of bladder cancer with diabetes drug

April 19, 2016 News

Medical professionals should be aware that a common diabetes drug has been found to increase the risk of bladder cancer, scientists in Canada have warned. The association between the drug pioglitazone and bladder cancer risk should be taken into account when assessing treatment so that all risks and benefits are discussed, said the team of […]

Read the full article →
Thumbnail image for Light activation could lead to new generation of type 2 diabetes drugs

Light activation could lead to new generation of type 2 diabetes drugs

April 12, 2016 News

Researchers in the UK have developed a light activated tool that could pave the way for a new generation of drugs to combat type 2 diabetes. The study provides insight into the signalling process of receptors in cells which means that drugs could be activated by the presence of either blue or ultra-violet light. “Current […]

Read the full article →
Thumbnail image for Study looks at benefits and downside of various drug combinations for diabetics

Study looks at benefits and downside of various drug combinations for diabetics

April 1, 2016 News

An observational study led by academics at the University of Nottingham in England has found important differences between diabetic drugs. The researchers compared drugs in terms of their ability to control blood sugar levels and prevent serious complications used alone and in different combinations. In particular they looked at the potential risks of blindness, amputation, […]

Read the full article →
Thumbnail image for Common drug may hold clue to effective treatment for diabetic heart attacks

Common drug may hold clue to effective treatment for diabetic heart attacks

February 10, 2016 News

People with diabetes can be more prone to cardiovascular disease but now it has been found that a common diabetes drug can be used to aid recovery from a heart attack. Heart disease is the leading cause of illness in diabetic patients and accounts for more than half of all fatalities but the solution could […]

Read the full article →
Thumbnail image for A simple drug patch could mean fewer diabetic amputations

A simple drug patch could mean fewer diabetic amputations

October 30, 2014 Treatment

Foot amputations, one of the most serious complications of diabetes, could become less prevalent as scientists have developed a new drug that helps lower limb ulcers heal better. The new drug can be administered through a skin patch and not only aids the healing process, but also prevents the wounds from recurring. This is especially […]

Read the full article →
Thumbnail image for New daily diabetes drug closer to being launched in the US

New daily diabetes drug closer to being launched in the US

January 3, 2014 Diabetes General

A panel of health advisers in the United States has backed the benefits of a diabetes drug that uses a new method to reduce blood sugar and it could get final approval for use in 2014. The Food and Drug Administration panel voted 13 to one in favour of the drug from Bristol-Myers Squibb and […]

Read the full article →
Thumbnail image for Top University Joins Astra Zeneca to Develop Drugs for Diabetes and Obesity

Top University Joins Astra Zeneca to Develop Drugs for Diabetes and Obesity

June 14, 2010 News

Columbia University Medical Center in New York and Astra Zeneca has signed a research partnership to develop therapeutic drugs for diabetes and obesity.  They announced recently that they have entered into a strategic research collaboration in metabolic related diseases and to develop novel therapeutics primarily in Type 2 diabetes and obesity, with a secondary focus […]

Read the full article →